Am J Transplant, Volume 21, Suppl 3 Archives - Page 31 of 139 - ATC Abstracts

2021 American Transplant Congress
Perioperative Blood Transfusion is Associated with the Development of New HLA Antibodies After Adult Lung Transplantation
A. Hicks¹, A. Stoker², M. Cooter², A. Ali³, J. Klapper⁴, J. Poisson⁵, D. Chen⁵, J. Haney⁴, K. Ghadimi², M. Hartwig⁴, I. Welsby², B. Bottiger²
¹Anesthesiology, Duke University Hospital, South Portland, ME, ²Anesthesiology, Duke University Hospital, Durham, NC, ³Pulmonology, Allergy and Critical Care Medicine, Duke University Hospital, Durham, NC, ⁴Cardiothoracic Surgery, Duke University Hospital, Durham, NC, ⁵Pathology, Duke University Hospital, Durham, NC
*Purpose: Lung transplant (LT) recipients who develop new antibodies to human leukocyte antigen (HLA) have associated with chronic lung allograft dysfunction and worsened outcomes. We…
2021 American Transplant Congress
Clinical Features and Outcomes of Candidemia in Patients with Left Ventricular Assist Devices
G. Krishnan, Y. Hamad, I. George
Infectious Diseases, Washington University School of Medicine, St Louis, MO
*Purpose: Fungal infections represent an uncommon etiology of Left Ventricular Assist Device (LVAD) infections but can lead to significant morbidity and mortality. In this study,…
2021 American Transplant Congress
Increasing Survival on the Kidney Transplant Waiting List: A Thirty-Three Year Analysis
E. L. Godfrey¹, P. T. Kambhampati¹, J. A. Goss², A. Rana²
¹Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The shortage of available donor kidneys remains the greatest obstacle to transplantation, with many patients spending years on the transplant list. During this time,…
2021 American Transplant Congress
T-Cell Responses in Solid Organ Transplant Recipients with SARS-CoV-2 Infection
V. H. Ferreira, T. M. Marinelli, T. Ku, M. Ierullo, B. Majchrzak-Kita, I. Bahinskaya, N. Pinzon, A. Humar, D. Kumar
University Health Network, Toronto, ON, Canada
*Purpose: Preliminary data suggest solid organ transplant (SOT) recipients may be at high-risk for developing severe COVID-19. This may be due in part to alterations…
2021 American Transplant Congress
Effects of Timing of Everolimus Transition on Renal Outcomes in Liver Transplant Recipients
M. Leick¹, H. Belleau², T. McCashland³
¹Nebraska Medicine, Omaha, NE, ²Bryan Health, Lincoln, NE, ³University of Nebraska Medical Center, Omaha, NE
*Purpose: The purpose of this study is to evaluate the effects of the timing of everolimus transition on renal outcomes in liver transplant recipients.*Methods: This…
2021 American Transplant Congress
Evaluate the Effect of Cresemba (isavuconazonium Sulfate) Capsule and Noxafil (posaconazole) Delayed Release Tablets on Tacrolimus Dose to Concentration (D/C) Ratios in Lung Transplant Recipients
H. Sweiss¹, E. Kincaide¹, D. Levine², R. Hall¹
¹University Health, San Antonio, Department of Pharmacotherapy and Pharmacy Services, The University of Texas at Austin, Pharmacotherapy Division, College of Pharmacy, San Antonio, TX, ²University Health, San Antonio, University of Texas Health Science Center at San Antonio, San Antonio, TX
*Purpose: Evaluate the effect of Cresemba (isavuconazonium sulfate) capsule and Noxafil (posaconazole) delayed release tablet on tacrolimus dose to concentration (D/C) ratio in lung transplant.*Methods:…
2021 American Transplant Congress
Additional Value to Participation in a National Paired Kidney Exchange Program: Exploring Characteristics of Chain End Living Donors and Waitlist Recipients
N. Osbun¹, A. Thomas², M. Cooper³, S. Flechner⁴, D. Segev², J. Veale¹
¹Urology, University of California Los Angeles, Los Angeles, CA, ²Johns Hopkins University, Baltimore, MD, ³Medstar Georgetown Transplant Institute, Washington DC, DC, ⁴Cleveland Clinic, Cleveland, OH
*Purpose: Non-directed kidney donors can initiate living donor chains that end to patients on the deceased donor waitlist. While many studies of paired exchange practices…
2021 American Transplant Congress
Liver Transplant Justified at Any Meld Score?
H. Oden-Brunson, E. Godfrey, H. Flores, A. Rana
Baylor College of Medicine, Houston, TX
*Purpose: Assessing the survival benefit of transplantation in patients with chronic liver failure is critical in guiding the decision-making process for liver allocation. Current protocols…
2021 American Transplant Congress
Psychosocial Factors Influencing Patients’ Decision Making About Upper Extremity Vca
B. Kuramitsu¹, J. Gacki-Smith¹, A. Ferzola², K. Vanterpool², C. Kunkle³, M. Hewitt³, A. Schultheis³, T. Riggleman³, J. Taylor³, C. Cooney², M. Levan², S. Tintle³, G. Brandacher², E. Gordon¹
¹Northwestern University, Chicago, IL, ²Johns Hopkins University, Baltimore, MD, ³Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: The informed consent process for upper extremity (UE) Vascularized Composite Allotransplantation (VCA) has yet to be standardized. Consequently, the information provided to patients about…
2021 American Transplant Congress
20 Year Survival Following Lung Transplantation
R. M. Reul, Jr¹, S. Barrett¹, A. Alnajar², J. Dunson¹, P. S. Garcha³, G. Loor⁴, J. A. Goss⁴, A. A. Rana⁴
¹Office of Student Affairs, Baylor College of Medicine, Houston, TX, ²Department of Surgery, University of Miami Health System, Miami, FL, ³Department of Medicine, Baylor College of Medicine, Houston, TX, ⁴Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Outcomes following lung transplantation (LTx) have been poor compared to those of heart, liver, and kidney transplants, with 5-year survival rates around 50%. To…